期刊文献+

原发性高血压患者颈动脉IMT与hsCRP的相关性研究 被引量:2

Relationship between carotid intima-media thickness and high sensitivity C-reactive protein in essential hypertension
下载PDF
导出
摘要 目的探讨原发性高血压患者颈动脉内膜—中膜厚度(IMT)与高敏C反应蛋白(hsCRP)的相关性。方法对145例原发性高血压患者及153例健康受试者进行颈动脉粥样硬化检测及血浆hsCRP测定,对测定结果进行统计学分析。结果高血压组IMT、hsCRP均明显高于对照组(P<0.01);hsCRP血浆水平与IMT年龄呈正相关(r=0.342,P<0.01)。结论hsCRP可能是高血压患者动脉粥样硬化的一个独立预测因子,可能参与了高血压病动脉粥样硬化的发生、发展。 Objective To investigate the relationship between carotid intima-media thickness (IMT) and high sensitivity C-reactive protein (hsCRP) in essential hypertension. Methods 145 cases of essential hypertension and 153 cases of healthy people were recruited. Carotid IMT was assessed by high frequency uhrasonography, and the level of plasma hsCRP was determined by enzyme-linked immunosorbent Assay (ELASA). Results IMT in hypertension group was thicker than that in control group ( P 〈 0.01 ). There was a significant difference between hypertension group and control group in level of plasma hsCRP ( P 〈 0.01 ). The level of plasma hsCRP was correlated positively with IMT and SBP respectively (r=0. 342,P〈0.01 and r=0.478,P 〈0.01). Conclusions The level of plasma hsCRP may be an independent prognostic factor for atherosclerosis in essential hypertension.
出处 《山东医药》 CAS 北大核心 2008年第27期33-34,共2页 Shandong Medical Journal
基金 山东省医药卫生科研项目(2007Hw147)
关键词 高血压 动脉硬化 C反应蛋白 essential hypertension atherosclerosis C-reactive protein
  • 相关文献

参考文献5

二级参考文献21

  • 1Clarkson P, Celermajer DS, Donald AE,et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels[J]. J Am Coll Cardiol, 1996,28(3):573-579.
  • 2Haverkate F, Thompson SG, Pyke SD,et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina[J]. Lancet, 1997,349(9050):462-466.
  • 3Sampietro T,Bigazzi F, Dal-Pino B,et al. Increased plasma C-reactive protein in familial hypoalphalipoproteinemia a proinflammatory condition[J]?Circulation,2002,105(1):11-14.
  • 4Rajamannan NM, Subramaniam M,Springett M,et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve[J]. Circulation,2002,105(22):2660-2665.
  • 5Mendall MA, Patel P,Ballam L,et al.C-reactive protein and its relation to cardiovascular-risk factors: a population based cross sectional study[J]. BMJ, 1996,312(7038):1061-1065.
  • 6Libby P,Ridker PM,Maseri A. Inflammation and atherosclerosis[J]. Circulation,2002,105(9):1135-1143.
  • 7Gambino R. C-reactive protein-undervalued, underutilized[J]. Clin Chem, 1997,43(11):2017-2018.
  • 8Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men[J].Am J Cardiol,1999,84(9):1018-1022.
  • 9Taylor WR. Hypertensive vascular disease and inflammation: mechanical and humoral mechanisms[J]. Curr Hypertens Rep, 1999, 1 (1): 96-101.
  • 10Celermajer DS, Admas MR,Clarkson P,et al. Passive smoking and impaired endothelium-dependent arterial dialatation in healthy young adults[J]. N Engl J Med, 1996,334(3):150-154.

共引文献68

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部